The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

The iCoapsys Repair System for the percutaneous treatment of functional mitral insufficiency

EuroIntervention Supplements (2006) 1 (Supplement A) A44-A48.

1. Minneapolis Heart Institute Foundation at Abbott Northwestern Hospital, Twin Cities Heart Foundation, Minneapolis, USA; 2. Emory University Hospital, Atlanta, USA; 3. Evanston Hospital, Evanston, USA

Functional mitral regurgitation (FMR) is a ventricular disease characterized by mitral valve insufficiency in the absence of structural abnormalities of the valve leaflets or sub-valvular apparatus.1 It commonly provokes heart failure and frequently confers an increase in patient mortality and morbidity. Medical therapy has a limited role for management of FMR. When treated, FMR is currently managed exclusively through open heart surgical techniques.


FMR may occur either in the presence of non-ischaemic dilated cardiomyopathy or in patients with regional wall motion abnormalities due to underlying ischaemic heart disease. More specifically, FMR results not only from ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Cardiac Dimensions®: percutaneous annuloplasty for functional mitral regurgitation